mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
-0.41 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.02 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.02 |